BCRX Financial Facts
Loss on foreign currency derivative: -931KTotal expenses: 17M
See Full Income Statement
Cash and cash equivalents: 35.39M
Total assets: 91.5M
See Full Balance Sheet
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings
|
Expand Research on BCRX
| Next EPS Date | 5/2/24 | EPS Growth Rate | +25.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.6% | Revenue Growth Rate | +26.2% |
| Average % Move 1-Wk after EPS | +2.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/21/23 | Q422 | -$0.38 | -$0.17 | -$0.21 | $79.5M | $75.57M | N/A |  | | Details | |
8/4/11  |
 |
Q211 | -$0.36 | -$0.25 | -$0.11 | $3.7M | $8.04M | N/A | | | Details |
| 5/4/11 |
|
Q111 | -$0.29 | -$0.20 | -$0.09 | $5.4M | $17.04M | N/A | | | Details |
| 8/8/13 |
Q213 | -$0.23 | -$0.14 | -$0.09 | $821K | $2.01M | N/A | | | Details | |
| 5/5/16 |
Q116 | -$0.31 | -$0.23 | -$0.08 | $4.82M | $5.42M | N/A | | | Details | |
| 10/28/10 |
|
Q310 | -$0.24 | -$0.17 | -$0.07 | N/A | N/A | N/A | | | Details |
| 2/23/22 |
Q4 | -$0.40 | N/A | N/A | $47.2M | $4M | N/A | | | Details | |
| 11/2/11 |
|
Q311 | -$0.32 | -$0.26 | -$0.06 | $5.25M | $6.84M | N/A | | | Details |
